Kidney Today from the American Kidney Fund brings you voices from the fight against kidney disease—patients, their loved ones, renal professionals and many others.

FDA issues first approval for a diabetes medicine that slows progression of CKD

Author: AKF Staff  |  Posted:

For individuals living with diabetes—the leading cause of kidney failure—the approval by the U.S. Food and Drug Administration of the diabetes medicine canagliflozin (brand name INVOKANA®) to treat diabetic kidney disease and reduce the risk of hospitalization for heart failure patients with type 2 diabetes and diabetic kidney disease is cause for optimism. READ MORE >>

TOPICS: News, Research, Kidney disease prevention
Items 1 - 8 of 152  12345678910Next

Connect with Us